Medpace Q4 2021 Earnings Report
Key Takeaways
Medpace Holdings, Inc. announced its Q4 and full year 2021 financial results, with Q4 revenue reaching $308.6 million, an 18.8% increase year-over-year, and net new business awards totaling $458.7 million, up 27.9% from the previous year. GAAP net income for Q4 was $50.0 million, or $1.32 per diluted share. The company provided financial guidance for 2022, forecasting revenue between $1.400 billion and $1.460 billion.
Q4 2021 revenue increased by 18.8% to $308.6 million compared to Q4 2020.
Net new business awards for Q4 2021 rose by 27.9% to $458.7 million, resulting in a book-to-bill ratio of 1.49x.
GAAP net income for Q4 2021 was $50.0 million, or $1.32 per diluted share.
The company forecasts 2022 revenue in the range of $1.400 billion to $1.460 billion.
Medpace
Medpace
Forward Guidance
The Company forecasts 2022 revenue in the range of $1.400 billion to $1.460 billion, representing growth of 22.6% to 27.8% over 2021 revenue of $1.142 billion. GAAP net income for full year 2022 is forecasted in the range of $204.0 million to $216.0 million. Additionally, full year 2022 EBITDA is expected in the range of $262.0 million to $278.0 million.